How much is the purchasing price of the Indian version of Epclusa?

Epclusa (Epclusa) is an all-oral, pan-genotypic treatment regimen against hepatitis C virus developed by Gilead. It mainly consists of sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir). It can effectively treat 1-6 types of hepatitis C virus and is suitable for most hepatitis C patients. At present, Jisandai has been officially launched in China and has been included in the medical insurance catalog. Patients can purchase this drug at domestic hospitals or pharmacies. After medical insurance reimbursement, the price at personal expense is about more than 3,000 yuan. The specific amount is subject to local medical insurance policies.

Although Jisandai is already available in China, some patients still prefer to obtain cheaper generic drugs through overseas purchasing due to economic reasons or access problems. At present, generic versions of Gynectin III are relatively common in the market in India and Bangladesh. These generic drugs have been approved by local drug regulatory agencies, contain the same active ingredients as the original drugs, and have similar therapeutic effects. Due to its low cost, the purchase price of the third generation of Indian version of Ji is usually around a few hundred yuan, which greatly reduces the patient's medication burden.

India's generic drugs are mostly produced by well-known generic drug companies such as Natco, Mylan and other companies, and have high production quality standards. Some cross-border medical service platforms, overseas pharmacies or medical intermediaries can provide purchasing services for these generic drugs. However, patients need to be extra cautious when choosing overseas purchasing channels to ensure that the medicines are from regular sources and are in good packaging to avoid buying fake and shoddy medicines.

Generally speaking, although domestic Jisandai has been included in medical insurance and its price has been significantly lower than that of the original drug, the price of generic drugs in India and Bangladesh still has obvious advantages, and it is one of the important choices for many patients with limited financial conditions. It is recommended that patients use drugs rationally under the guidance of doctors and ensure that drugs are purchased through formal channels to ensure treatment effects and drug safety.

Reference: https://www.epclusa.com/